[e-drug] Civil Society delegations to UNITAID Board - brief report 20th UNITAID Board meeting

E-DRUG: Civil Society delegations to UNITAID Board - brief report 20th UNITAID Board meeting
------------------------------------------------------------------------------------------------------------------

Brief Report on 20th UNITAID Executive Board Meeting
12-13 June 2014, Geneva

The Civil Society delegations to the UNITAID Board (representing
Communities affected by HIV/AIDS, TB and malaria, and NGOs working on the
global response to the three diseases) attended the 20th UNITAID Board
meeting in June 2014 in Geneva.

The meeting focused on the recruitment of a new Executive Director, now
confirmed as Mr Lelio Marmora, formerly Head of the Global Fund?s West
Africa and Middle East department. See
http://www.unitaid.eu/en/resources/press-centre/3-news/press/1377-mr-lelio-marmora-joins-unitaid-as-executive-director
for more information.

Additional discussions took place on a new formal collaboration agreement
between UNITAID and The Global Fund, announced at the meeting (
http://www.unitaid.eu/en/resources/press-centre/3-news/press/1361-unitaid-and-the-global-fund-announce-formal-collaboration
), and the Medicines Patent Pool?s recent progress and current priorities,
amongst others.

Resolutions from the Board meeting are available at
http://www.unitaid.eu/en/how/gov/resolutions/9-uncategorised/1362-eb-20-resolutions

A full report on the discussions and outcomes at the 20th UNITAID Board
meeting is available from the Civil Society delegations? Liaison Officer,
to all members of the Civil Society delegations? Contact Group.

Any representative of a Community affected by HIV/AIDS, TB or malaria, or
of an NGO working to fight the three diseases, may join the Civil Society
delegations? to UNITAID Contact Group. Please contact the delegations?
Liaison Officer Jessica Hamer (jhamer@oxfam.org.uk) in order to join the
Contact Group, and receive a copy of the full delegations? report.

What is UNITAID?
UNITAID is an innovative global health initiative that uses its long-term
sustainable funding to support projects that positively impact the market
for medicines, diagnostics and other health products for HIV/AIDS, TB and
malaria in developing countries. UNITAID raises money through a
combination of levies on airline tickets and long-term government funding.
UNITAID also encourages innovation to ensure medicines are available in
formulations and combinations that are best suited to the target
populations and treatment conditions in developing countries.
What are the Civil Society Delegations?

The UNITAID Board has 12 seats, including one seat for communities
affected by HIV, TB or malaria, and another seat for NGOs involved in the
global fight against these diseases. Each board seat allows for one board
and one alternate board member at the table. Together, the Communities and
NGOs delegates to the UNITAID Board form the Civil Society Delegations.
Communities and NGOs Board Members choose to work together a great deal
but constitute two distinct delegations, each with its own voice and
strengths.

Jessica Hamer |
Liaison Officer, Civil Society Delegations to UNITAID Board
Jessica Hamer <JHamer@oxfam.org.uk>